Mayne Pharma | Lånekapital



Loan Capital Lave om Dato
Ansell USD 706.6M 319.8M 2024-06
Avita Medical AUD 42.24M 1.25M 2024-12
Cochlear AUD 202.1M 35.2M 2024-06
CSL USD 11.24B 552M 2024-06
Ecofibre AUD 9.5M 0 2024-06
Healius AUD 1.22B 103M 2024-12
Integral Diagnostics AUD 341.63M 1.98M 2024-06
Medical Developments International AUD 1.91M 146K 2024-06
Nanosonics AUD 6.16M 1.47M 2024-06
Next Science USD 568.96K 118.2K 2024-06
Polynovo AUD 12.84M 857K 2024-06
Ramsay Health Care AUD 10.69B 359.3M 2024-12
ResMed USD 662.86M 4.72M 2024-12
Sigma Healthcare AUD 124.31M 2.53M 2024-07
Sonic Healthcare AUD 4.19B 333.39M 2024-12
Telix Pharmaceuticals AUD 551.82M 533.46M 2024-12



Mayne Pharma Lånekapital - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.